Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants.

European journal of clinical pharmacology - 1 Oct 2023

Wang Dongxu, Wu Hualan, Zhang Qing, Zhou Xiaoyue, An Yang, Zhao Anxu, Chong Jia, Wang Shuanghu, Wang Fang, Yang Jiefu, Dai Dapeng, Chen Hao

Abstract excerpt

BACKGROUND: Existing pharmacogenetic algorithms cannot fully explain warfarin dose variability in all patients. CYP2C9*13 is an important allelic variant in the Han Chinese population. However, adjustment of warfarin dosing in CYP2C9*13 variant carriers remains unclear. To the best of our knowledge, this study is the first to assess the effects of adjusting warfarin dosages in Han Chinese patients harbouring...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Dose-Response Relationship, Drug

Share to East Asian People

Share to Genotype

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 37458773
DOI: 10.1007/s00228-023-03540-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants.PMID 37458773Read ↗

Optimisation of Warfarin-Dosing Algorithms for Han Chinese Patients with CYP2C9*13 VariantsSemantic proximity Read ↗

Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation.Semantic proximity Read ↗

A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.Semantic proximity Read ↗

Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients.Semantic proximity Read ↗

[Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population].Semantic proximity Read ↗

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.Semantic proximity Read ↗

Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population.Semantic proximity Read ↗

Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation.Semantic proximity Read ↗

To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study.Semantic proximity Read ↗

Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C.Semantic proximity Read ↗

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.Semantic proximity Read ↗

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.